Skip to content

To evaluate and compare the efficacy of intravenous antagonists in preventing shivering during elective LSCS under subarachnoid block.

To evaluate the efficacy of intravenous ondansetron and granisetron in preventing perioperative shivering in patients undergoing elective LSCS under subarachnoid blockade - A prospective randomized double blinded comparative study. - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064015
Enrollment
60
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ondansetron: Single Dose, Intravenous ondansetron 0.1mg/kg Control Intervention1: Granisetron: Single dose, Intravenous granisetron 0.01mg/kg

Sponsors

Dr Ashwini R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Parturients willing to give informed and written consent •ASA physical status II •Parturients with Body Mass Index 20 – 30 Kg / M2 •Elective LSCS with singleton pregnancy

Exclusion criteria

Exclusion criteria: 1.Parturients with known hypersensitivity to the study drugs 2.Parturients who have received the study drugs 24 hours before the surgery. 3.Parturients with emetic episodes 24 hours prior to the surgery 4.Parturients who are on opioids, who require sedation, intraoperative blood transfusion. 5.Parturients with pre operative temperature = 38 ? C or = 36.6 ? C 6.Parturients having Parkinson’s disease or movement disorders or seizures.

Design outcomes

Primary

MeasureTime frame
Perioperative shiveringTimepoint: 5 mins, 10 mins, 15 mins, 20 mins, 25 mins, 30 mins followed by every 30 minutes till return of modified bromate scale of 6

Secondary

MeasureTime frame
Vitals AssessmentTimepoint: 0 mins, 30 mins, 60 mins, 2 hours

Countries

India

Contacts

Public ContactDr Yoganarasimha N

BGS Global Institute of Medical Sciences

yogabmc98@yahoo.co.in7813922138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026